Ryan L Davis
Overview
Explore the profile of Ryan L Davis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sullivan P, Quinn J, Ajuyah P, Pinese M, Davis R, Cowley M
Am J Hum Genet
. 2025 Mar;
PMID: 40056912
Disease-causing genetic variants often disrupt mRNA splicing, an intricate process that is incompletely understood. Thus, accurate inference of which genetic variants will affect splicing and what their functional consequences will...
2.
Fellner A, Wali G, Mahant N, Grosz B, Ellis M, Narayanan R, et al.
Parkinsonism Relat Disord
. 2024 May;
124:107010.
PMID: 38772265
Purpose: We investigated the contribution of genomic data reanalysis to the diagnostic yield of dystonia patients who remained undiagnosed after prior genome sequencing. Methods: Probands with heterogeneous dystonia phenotypes who...
3.
Kumar K, Cowley M, Davis R
Semin Thromb Hemost
. 2024 May;
50(7):1039-1046.
PMID: 38733978
No abstract available.
4.
Kumar K, Cowley M, Davis R
Semin Thromb Hemost
. 2024 May;
50(7):1026-1038.
PMID: 38692283
Genetic sequencing technologies are evolving at a rapid pace with major implications for research and clinical practice. In this review, the authors provide an updated overview of next-generation sequencing (NGS)...
5.
Yeow D, Rudaks L, Siow S, Davis R, Kumar K
Tremor Other Hyperkinet Mov (N Y)
. 2024 Jan;
14:2.
PMID: 38222898
Highlights: The utility of genetic testing extends across multiple clinical and non-clinical domains. Here we review different aspects of the utility of genetic testing for movement disorders and the numerous...
6.
Sullivan P, Gayevskiy V, Davis R, Wong M, Mayoh C, Mallawaarachchi A, et al.
Genome Biol
. 2023 May;
24(1):118.
PMID: 37198692
Predicting the impact of coding and noncoding variants on splicing is challenging, particularly in non-canonical splice sites, leading to missed diagnoses in patients. Existing splice prediction tools are complementary but...
7.
Xu X, Lubomski M, Holmes A, Sue C, Davis R, Muller S, et al.
Microbiome
. 2023 Mar;
11(1):51.
PMID: 36918961
Background: Unrevealing the interplay between diet, the microbiome, and the health state could enable the design of personalized intervention strategies and improve the health and well-being of individuals. A common...
8.
Davis R, Kumar K, Watson E, Sue C
Neurology
. 2022 Dec;
100(1):50.
PMID: 36572543
No abstract available.
9.
Watson E, Davis R, Ravishankar S, Copty J, Kummerfeld S, Sue C
Am J Hum Genet
. 2022 Dec;
110(1):166-169.
PMID: 36565700
The risk of Leber hereditary optic neuropathy (LHON) has largely been extrapolated from disease cohorts, which underestimate the population prevalence of pathogenic primary LHON variants as a result of incomplete...
10.
Lubomski M, Xu X, Holmes A, Muller S, Yang J, Davis R, et al.
Front Aging Neurosci
. 2022 Jun;
14:875261.
PMID: 35656540
Background: Altered gut microbiome (GM) composition has been established in Parkinson's disease (PD). However, few studies have longitudinally investigated the GM in PD, or the impact of device-assisted therapies. Objectives:...